logo

Dong Won Kim, PharmD candidate

home / authors / dong-won-kim-pharmd-candidate

Articles

TXNIP inhibitors: A New Class of Agents for Diabetes Treatment

TXNIP inhibitors: A New Class of Agents for Diabetes Treatment

Jane Doan, PharmD candidate;Kylie Martens, PharmD candidate;Andrea Lee, PharmD Candidate;Dong Won Kim, PharmD candidate;Alexandra Burger, PharmD;Nikhil A. Sangave, PharmD, BCACP
December 22nd 2021

TXNIP inhibition could prevent beta cell loss and protect beta cell function to potentially contribute to diabetes management and its complications.

Read More

Latest Updated Articles

Anatomy of Human Heart on medical background. 3d render - Image credit: ckybe | stock.adobe.com
Published: March 10th 2025 | Updated: March 21st 2025
Pharmacists Will Play an Essential Role in Optimizing Vutrisiran Therapy for ATTR-CM
Image credit: toeytoey | stock.adobe.com
Published: March 12th 2025 | Updated: March 18th 2025
MDMA Rejected: The Story of a Study Participant Entrenched in Ethical Violations
Blood test for graft-vs-host-disease (GVHD) -- Image credit: MdBabul | stock.adobe.com
Published: February 26th 2025 | Updated: March 14th 2025
Navigating Steroid-Refractory GVHD Treatment: A Pharmacist’s Guide to Medication Management
fda on paper texture - Image credit: Araki Illustrations | stock.adobe.com
Published: March 7th 2025 | Updated: March 10th 2025
FDA Approves Interchangeable Biosimilar to Xolair
Benjamin Franklin on US dollar surrounded by pills | Image Credit: © Cagkan - stock.adobe.com
Published: January 22nd 2025 | Updated: January 28th 2025
Reversal of Executive Order 14087 Raises Questions About Future Drug Pricing Reforms
A pregnant woman sits on a bed, holding a glass of water in one hand while preparing to take prenatal vitamins in the other. She appears thoughtful and focused on her health - Image credit: Prostock-studio | stock.adobe.com
Published: December 18th 2024 | Updated: January 2nd 2025
Study Shows Choline and Iodine Are Missing Links in Prenatal Supplements